Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.

about

Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome.

P2860

Q42923596-D74AC11A-2F40-4D80-B736-CE8AC2F66938

P2860

Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.

Item

http://www.wikidata.org/entity/Q36806501

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Last marrow standing: bone mar ...... one marrow failure conditions.

@ast

Last marrow standing: bone mar ...... one marrow failure conditions.

@en

type

Item

label

Last marrow standing: bone mar ...... one marrow failure conditions.

@ast

Last marrow standing: bone mar ...... one marrow failure conditions.

@en

prefLabel

Last marrow standing: bone mar ...... one marrow failure conditions.

@ast

Last marrow standing: bone mar ...... one marrow failure conditions.

@en

P1476

Last marrow standing: bone mar ...... bone marrow failure conditions

@en

P2093

Bart L Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases

International scoring system for evaluating prognosis in myelodysplastic syndromes

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party

Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

P2888

s11899-012-0138-x

P304

292-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-012-0138-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aaron T Gerds

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232247828

http://www.w3.org/2001/XMLSchema#string

P698

23065408

http://www.w3.org/2001/XMLSchema#string

P921

bone marrow

P932

3640337

http://www.w3.org/2001/XMLSchema#string

Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.

about

P2860

P2860

Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932